Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

  1. Ghia, P.
  2. Pluta, A.
  3. Wach, M.
  4. Lysak, D.
  5. Šimkovič, M.
  6. Kriachok, I.
  7. Illés, Á.
  8. De La Serna, J.
  9. Dolan, S.
  10. Campbell, P.
  11. Musuraca, G.
  12. Jacob, A.
  13. Avery, E.J.
  14. Lee, J.H.
  15. Usenko, G.
  16. Wang, M.H.
  17. Yu, T.
  18. Jurczak, W.
Journal:
HemaSphere

ISSN: 2572-9241

Year of publication: 2022

Volume: 6

Issue: 12

Pages: E801

Type: Article

DOI: 10.1097/HS9.0000000000000801 GOOGLE SCHOLAR lock_openOpen access editor